SecBot SecBot
DEFA14A ·Filed Oct 6, 2026

SUPN

SUPERNUS PHARMACEUTICALS, INC.
NEUTRAL
Impact 3/10
Horizonweeks Processed23d 8h ago SEC0001104659-26-113882
Proxy solicitation materials
Actionable Insight • Neutral

Monitor the October 15 special meeting for stockholder approval; the litigation risk appears resolved by these supplemental disclosures, but any further stockholder lawsuits or ISS/Glass Lewis recommendations could affect the vote outcome.

DirectionNeutral
Confidencehigh
Horizonweeks
Latest settled: T+5d ⚠ clustered
SUPN ▼ -1.91% at T+5d
NEUTRAL call -1.91% · α vs SPY -1.78% · entry $42.83 → $42.01
Next anchor: T+20d in 5d
Latest observation: T+13 -3.59% FF3 residual α
Entry = T+0 close
Oct 6, 2026
via day close
T+1d
+0.51%
call +0.51% · α +0.75%
$43.05
settled 22d ago
T+5d
-1.91%
call -1.91% · α -1.78%
$42.01
settled 16d ago
T+20d
Pending
in 5d
T+60d
Pending
in 2mo

Price Chart

Loading chart...

Executive Summary

Supernus filed a DEFA14A supplementing its merger proxy statement with Indivior to address stockholder litigation alleging disclosure deficiencies. The supplement provides additional detail on Cantor Fitzgerald's financial analyses, including cash/debt figures and fully diluted share counts, but management denies any legal necessity for the changes. The merger vote is scheduled for October 15, 2026, and this filing is a routine litigation-mooting exercise with no material impact on deal terms or likelihood.

Key Financial Metrics

Vote
merger approval
Meeting
2026-10-15

Key Facts

  • Supernus received demand letters and two complaints alleging disclosure deficiencies in the merger proxy statement.
  • Supernus and Indivior voluntarily supplemented the proxy statement with additional detail on Cantor Fitzgerald's financial analyses, without admitting liability.
  • The special meeting of Supernus stockholders to vote on the merger is scheduled for October 15, 2026.
  • Supplemental disclosures include Supernus estimated cash of ~$372M and zero debt; Indivior estimated cash of ~$249M and debt of ~$500M.
  • Cantor's DCF analysis implied a per-share equity value reference range for Supernus of $50.55 to $59.50.
  • Cantor's DCF analysis implied a dividend-adjusted per-share equity value reference range for Indivior of $24.20 to $43.90.

Financial Impact

No change to merger consideration or deal structure; supplemental disclosures are procedural and do not alter the $1 billion Special Dividend or exchange ratio.

Risk Factors

  • Stockholder litigation could still delay or derail the merger if additional claims emerge.
  • Failure to obtain required stockholder approvals at the October 15 meeting would terminate the merger.
  • Regulatory approvals or other closing conditions may not be satisfied.

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
DEFA14A Filing (Primary)0001104659-26-113882
Document: 0001104659-26-113882-index-headers.html0001104659-26-113882
Document: 0001104659-26-113882-index.html0001104659-26-113882
Document: 0001104659-26-113882.txt0001104659-26-113882
27 reports for SUPN
Performance horizon
67% Hit rate @ T+5 6 of 9 directional calls Went positive at some point 7 of 11 best @ T+60▲ +16.06%Jul 20, 2026
Filters
Rows
Reports for SUPN, sortable and filterable
TypeNow
Oct 26, 2026
2d ago
8-K
NEUTRAL ★ 2/10
$40.96awaiting T+5awaiting T+5$41.59 (+1.54%)
Oct 26, 2026
3d ago
Court Ruling
BEARISH ★ 5/10
$40.96awaiting T+5awaiting T+5$41.59 (−1.54%)
Oct 21, 2026
7d ago
8-K
BULLISH ★ 6/10
$42.07awaiting T+5awaiting T+5$41.59 (−1.14%)
Oct 19, 2026
9d ago
8-K
NEUTRAL ★ 2/10
$41.23 $40.54▼ −1.67%▼ −1.70%$41.59 (+0.87%)
Oct 19, 2026
10d ago
Press Release
NEUTRAL ★ 1/10
$39.84 $40.63▲ +1.98%▲ +2.13%$41.59 (+4.39%)
Oct 6, 2026
23d ago
425
NEUTRAL ★ 4/10
$42.83 $42.01▼ −1.91%▼ −1.78%$41.59 (−2.90%)
Oct 6, 2026
23d ago
DEFA14A
NEUTRAL ★ 3/10
$42.83 $42.01▼ −1.91%▼ −1.78%$41.59 (−2.90%)
Sep 11, 2026
6w ago
DEFM14A
MIXED ★ 7/10
$41.49 $42.78▲ +3.11%▲ +3.00%$41.59 (+0.24%)
Aug 3, 2026
12w ago
DEFA14A / 425
BULLISH ★ 7/10
$43.25 $46.88▲ +8.39%▲ +8.49%$41.59 (−3.84%)
Aug 3, 2026
12w ago
8-K
BULLISH ★ 7/10
$43.25 $46.88▲ +8.39%▲ +8.49%$41.59 (−3.84%)
Showing 10 of 27

US Market Status

Market Open · Closes in 6m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 6, 2026